Drug Type siRNA |
Synonyms |
Target |
Mechanism FUS inhibitors(FUS RNA binding protein inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization Ractigen TherapeuticsStartup |
Active Organization Ractigen TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Discovery | CN | Ractigen TherapeuticsStartup | 07 May 2023 |